Skip to main content

Table 2 Clinical characteristics among the studied groups

From: Helicobacter pylori infection in patients with metabolic syndrome, with or without nonalcoholic fatty liver disease

  Total N = 300 Control N = 100 Metabolic with NAFLD N = 100 Metabolic without NAFLD N = 100 Test of significance Within group significance
Weight (kg) 83.22 ± 17.63 74.35 ± 9.46 95.80 ± 23.41 79.51 ± 6.93 F = 54.86
P < 0.001*
p1 < 0.001*
p2 = 0.016*
p3 < 0.001*
Height (cm) 170.21 ± 10.94 171.92 ± 8.94 169.87 ± 13.47 168.84 ± 9.75 F = 2.07
P = 0.13
p1 = 0.18
p2 = 0.04*
p3 = 0.50
BMI (kg/m2) 28.91 ± 7.04 25.28 ± 3.08 33.18 ± 10.03 28.28 ± 2.74 F = 40.49
P < 0.001*
p1 < 0.001*
p2 < 0.001*
p3 = 0.001*
Waist circumference (cm) 100.73 ± 13.40 118.40 ± 16.27 102.15 ± 10.51 107.09 ± 15.75 F = 52.12
P < 0.001*
p1 < 0.001*
p2 = 0.46
p3 = 0.001*
Systolic blood pressure (mmHg) 129.77 ± 22.64 114.6 ± 15.0 133.90 ± 25.30 140.80 ± 17.6 F = 47.06
P < 0.001*
p1 < 0.001*
p2 < 0.001*
p3 = 0.01*
Diastolic blood pressure (mmHg) 82.17 ± 9.48 75.0 ± 8.34 84.60 ± 8.09 86.90 ± 7.48 F = 62.54
P < 0.001*
p1 < 0.001*
p2 < 0.001*
p3 = 0.04*
  1. *statistically significant value
  2. F one way ANOVA test, χ2 Chi-square test, all parameters described as mean ± SD, number and percentage, p1 difference between control and metabolic with NAFLD group, p2 difference between control and metabolic without NAFLD group, p3 difference between metabolic with and without NAFLD